In this Product Explainer, Dermatologist Dr Ryan De Cruz, explains the role of calcipotriol and betamethasone dipropionate foam spray for the topical treatment of psoriasis vulgaris in adults (6 mins).
In this Product Explainer Dermatologist A/Prof Deshan Sebaratnam explains the role of pimecrolimus cream in the management of atopic dermatitis/eczema where the use of a topical corticosteroid is not considered suitable (5 mins).
There are a wide variety of acne treatments – including some new arrivals that GPs might find useful. Dermatologist and leading acne expert, Dr Jo-Ann See, presents what's new in the understanding, assessment and treatment of acne, the very common and depressing skin condition not only of adolescents, but also of young adults. In addition, Jo-Ann will outline the latest evidence-based recommendations for prescription treatment and treatment combinations, suggest effective adjunctive skincare, and give practical indicators for when specialist referral is warranted.
Sun-related skin damage, also known as photoageing, is the most common reason that patients seek out cosmetic treatment from dermatologists. Australians experience much higher levels of photoageing compared to people in other countries, manifesting as fine lines and wrinkles, brown spots, skin texture changes and redness. Dr Katherine Armour will describe the procedures and treatments available for the various manifestations of photoageing that your patients are asking you about, and gives you a practical understanding of the effectiveness and realistic expectations that each option entails.
In this Product Explainer, Dermatologist Dr Ryan De Cruz, explains the role of fluorouracil and salicylic acid topical liquid for the treatment of Actinic Keratoses (6 mins).
In this Product Explainer, Dermatologist Dr Ryan De Cruz, explains the role of calcipotriol and betamethasone dipropionate foam spray for the topical treatment of psoriasis vulgaris in adults (6 mins).
When deciding whether to administer Zostavax or not, it’s useful to keep the three types of immunocompromised patients in mind – the mild, the moderate and the severe, says infectious disease physician and virologist Professor Tony Cunningham.
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.